Search Results - "Ravali, Sahithya"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    A systematic review of artificial intelligence for pediatric physiotherapy practice: Past, present, and future by Ravali, Ravula Sahithya, Vijayakumar, Thangavel Mahalingam, Santhana Lakshmi, Karunanidhi, Mavaluru, Dinesh, Reddy, Lingala Viswanath, Retnadhas, Mervin, Thomas, Tintu

    Published in Neuroscience informatics (01-12-2022)
    “…Background: Artificial intelligence (AI) is one of the active research fields to develop systems that mimic human intelligence and is helpful in many fields,…”
    Get full text
    Journal Article
  2. 2

    Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells by Suksatan, Wanich, Chupradit, Supat, Yumashev, Alexei Valerievich, Ravali, Sahithya, Shalaby, Mohammed Nader, Mustafa, Yasser Fakri, Kurochkin, Anatoley, Siahmansouri, Homayoon

    Published in International immunopharmacology (01-12-2021)
    “…•An inflammatory immune response targeting children with COVID-19 is named MIS-C.•Characteristics of MIS-C include the classic inflammation findings, fever as…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Trachyspermum copticum essential oil incorporated niosome for cancer treatment by Trinh, Le Huy, Takzare, Alireza, Ghafoor, Dlzar D., Siddiqi, Ahmed Faisal, Ravali, Sahithya, Shalbaf, Mohammad, Bakhtiar, Mahdiyeh

    “…The Trachyspermum copticum essential oil (TCEO) has been incorporated into niosomes (NIO-TCEO). The chemical composition of the TCEO has been evaluated using…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Medical Insurance Premium Prediction Using Linear Support Vector Machine by Linija, K P, S, Geetha, Mavaluru, Dinesh, Ravali, Sahithya, Mary, S Angel Latha

    “…In healthcare, data mining algorithms are utilized to make people's lives better by predicting diseases and trying to diagnose them faster than most doctors…”
    Get full text
    Conference Proceeding
  10. 10

    A randomized open-label trial of the efficacy of ranolazine in patients with type 2 diabetic dyslipidemia by Ravali, Ravula Sahithya, Lakshmi, Karunanidhi Santhana, Vijayakumar, Thangavel Mahalingam, Kumar, Janardanan Subramonia

    Published in Obesity medicine (01-09-2021)
    “…Ranolazine is an oral antianginal drug that has been proven effective in reducing HbA1c and fasting plasma glucose levels in patients with type 2 diabetes in…”
    Get full text
    Journal Article